Datasheet | June 5, 2015

Cardio-Metabolic: Clinical Development and Consultative Services

Source: PRA Health Sciences

PRA Health Sciences (PRA) provides comprehensive clinical development and consultative services to support our clients’ cardio-metabolic studies. As the cornerstone of our cardio-metabolic disease program, our in-house team of therapeutic experts collaborate with our network of key opinion leaders and investigators, to mine insightful data and analyze how they will benefit our clients’ trials. Our experience spans more than 20 indications, and we have participated in the successful market approval of 6 cardio-metabolic drugs.

PRA's global investigator network has enabled us to establish preferred access to investigative sites that are able to accrue patients and deliver high-quality clinical trial data.